hotspot -WSS

hotspot

author：Wikipedia 2025-08-08 05:32:55 - browse：6

Photo of an arrangement of aspirin pills — Patrick Sison/AP

Low-dose aspirin led to a reduction in liver fat among patients with metabolic-associated liver disease, a small study out of Boston found.

The clinical trial, led by Tracey Simon of Massachusetts General Hospital and Harvard Medical School, compared two groups of patients with metabolic dysfunction-associated steatotic liver disease, or MASLD. One group was given baby aspirin daily for six months, while the other received a placebo pill. At the end of the study period, the aspirin group had reduced hepatic fat content while the placebo group had higher fat buildup.

MASLD (formerly known as non-alcoholic fatty liver disease) is a growing health threat, with 1 in 3 Americans having a troublesome amount of fat in their liver. The lipid buildup feeds into a toxic cycle of inflammation, tissue damage and, ultimately, irreversible scarring.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： As AI in medicine takes off, can 'human in the loop' prevent harm?

WSS

What should King Charles tell the public about his cancer?

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

Biden report: The neurospychology of memory and aging

Gilead might be held responsible for not developing a drug

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

Readout Newsletter: Bristol, Sangamo, Gilead, and more

focus

hotspot

leisure time

Virginia high school admissions case could be legal follow

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

Peter Hotez and the public health issue of online harassment

Male and female sex labels in research insufficient, scientists say

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

How digital tools helped lower hypertension in marginalized patients

Medicare proposal to cover medical devices draws a mixed reaction

KalVista pill reduced swelling 'attacks' caused by genetic disease

Apple is now the first public company to be valued at $3 trillion

How many hemophilia patients actually want gene therapy?

hotspot

KalVista pill reduced swelling 'attacks' caused by genetic disease

How many hemophilia patients actually want gene therapy?

Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

Key House Republican on health care plans exit from Congress

Vaccine advisory panel ACIP left half staffed by HHS

WuXi out of biotech trade group, U.S. and China relations to blame

Wikipedia

hotspot

knowledge

entertainment